As of 1:03pm ET
| -0.65 / -1.38%|
The 2 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 52.50, with a high estimate of 65.00 and a low estimate of 40.00. The median estimate represents a +13.24% increase from the last price of 46.36.
The current consensus among 2 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.